Dicot Pharma AB Statistics

Total Valuation

Dicot Pharma AB has a market cap or net worth of SEK 1.19 billion. The enterprise value is 1.10 billion.

Market Cap	1.19B
Enterprise Value	1.10B

Important Dates

The next estimated earnings date is Friday, August 22, 2025.

Earnings Date	Aug 22, 2025
Ex-Dividend Date	n/a

Share Statistics

Dicot Pharma AB has 2.01 billion shares outstanding. The number of shares has increased by 102.30% in one year.

Current Share Class	2.01B
Shares Outstanding	2.01B
Shares Change (YoY)	+102.30%
Shares Change (QoQ)	-22.18%
Owned by Insiders (%)	10.23%
Owned by Institutions (%)	14.00%
Float	1.68B

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	13.48
P/TBV Ratio	13.48
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-16.40
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 7.27

Current Ratio	7.27
Quick Ratio	6.95
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-6,917.90

Financial Efficiency

Return on equity (ROE) is -112.45% and return on invested capital (ROIC) is -72.57%.

Return on Equity (ROE)	-112.45%
Return on Assets (ROA)	-61.29%
Return on Invested Capital (ROIC)	-72.57%
Return on Capital Employed (ROCE)	-78.26%
Revenue Per Employee	n/a
Profits Per Employee	-22.33M
Employee Count	3
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +7.54% in the last 52 weeks. The beta is 1.69, so Dicot Pharma AB's price volatility has been higher than the market average.

Beta (5Y)	1.69
52-Week Price Change	+7.54%
50-Day Moving Average	0.46
200-Day Moving Average	0.30
Relative Strength Index (RSI)	53.92
Average Volume (20 Days)	25,936,109

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-69.18M
Pretax Income	-67.00M
Net Income	-67.00M
EBITDA	-69.17M
EBIT	-69.18M
Earnings Per Share (EPS)	-0.05

Full Income Statement

Balance Sheet

The company has 92.80 million in cash and n/a in debt, giving a net cash position of 92.80 million or 0.05 per share.

Cash & Cash Equivalents	92.80M
Total Debt	n/a
Net Cash	92.80M
Net Cash Per Share	0.05
Equity (Book Value)	88.40M
Book Value Per Share	0.05
Working Capital	88.40M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-63.77M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Dicot Pharma AB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-102.30%
Shareholder Yield	n/a
Earnings Yield	-5.62%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2